The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
Heterozygous mutations of the receptor CD95 (Fas/Apo-1) are associated with defective lymphocyte apoptosis and a clinical disease characterized by lymphadenopathy, splenomegaly, and systemic autoimmunity. From our cohort of 11 families, we studied eight patients to define the mechanisms responsible...
Gespeichert in:
| Veröffentlicht in: | J Clin Invest |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
1999
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC407903/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9927496/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI5121 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|